Concepedia

Barbara Schmalfeldt

BS

Statistics

Publications

90

Citations

5.8K

H-Index

41

Active since

1994

Affiliations

University Medical Center Hamburg-Eppendorf(Current)

Universität Hamburg

Technical University of Munich

TUM Klinikum

Mount Sinai Hospital

Barbara Schmalfeldt is an author at University Medical Center Hamburg-Eppendorf specializing in medicine, oncology, and ovarian cancer.

ORCID

Publications per year

1994–2025

90

Publications

90

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

M. M. Heiss, P. Murawa, P. Koralewski et al. · International Journal of Cancer · 2010 · 551 citations · Full text

, , +15

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

Barbara Schmalfeldt, Dieter Prechtel, Kathrin Härting et al. · PubMed · 2001 · 336 citations

, , +16

Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer

Norbert Avril, Stefanie Sassen, Barbara Schmalfeldt et al. · Journal of Clinical Oncology · 2005 · 281 citations

, , +15

CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer

Holger Bronger, J. David Singer, Claudia Windmüller et al. · British Journal of Cancer · 2016 · 272 citations · Full text

, , +17

Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study

Alexander Burges, Pauline Wimberger, Carolin Kümper et al. · Clinical Cancer Research · 2007 · 257 citations

, , +17

1–5 of 90